VAERS reports by lot

Merck Pneumococcal lot U034712: VAERS reports

45 VAERS reports list lot U034712 as a Merck Pneumococcal vaccine, received between 2022-04-25 and 2024-02-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3039%
General / Systemic (non-local)1722%
Allergic / Anaphylactic912%
Dermatological (non-injection-site)810%
Neurological56%
Cardiac / Cardiovascular56%
Gastrointestinal23%
Musculoskeletal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas10
New York4
California4
Wisconsin3
Arizona2
Pennsylvania2
North Carolina2
Maryland2
Virginia2
Washington2
Colorado1
Nevada1

Reports by month received

2022-041
2022-051
2022-069
2022-076
2022-083
2022-092
2022-104
2022-111
2022-121
2023-013
2023-022
2023-031
2023-041
2023-051
2023-063
2023-082
2023-092
2023-101
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.